Global Controlled Release Drug Delivery Technology Market by Region, 2020-2029, (USD Million) (Thousand Units) Global Controlled Release Drug Delivery Technology Market by Application, 2020-2029, (USD Million) (Thousand Units) Global Controlled Release Drug Delivery Technology Market by Technology Outlook, 2020-2029, (USD Million) (Thousand Units) ► What exactly does market segmentation cover? As more than 70% of new small molecules are insoluble, Eudratec SoluFlow enables the development of new oral therapeutics in diverse areas, such as cancer, cardiovascular diseases, infectious diseases, and diabetes. March 2022: Evonik launched Eudratec SoluFlow, a new microparticle technology to enhance the solubility of active pharmaceutical ingredients in oral drug products. June 2022: A research study was conducted at the University of Michigan that demonstrated a new method of drug microencapsulation, allowing several peptide drugs to be slowly released into the body. Recent developments in Controlled Release Drug Delivery industry, even after market report release, support market trends outlined in analysis. ► Recent Developments in Controlled Release Drug Delivery Market Orbis Biosciences, Inc., Merck and Co., Inc., Alkermes plc, Johnson and Johnson, Coating Place, Inc., Corium International, Inc., Depomed, Inc., Pfizer, Inc, Aradigm Corporation, Capsugel, and others. ►Who are the major players in this industry? Regional reports that can be customised upon request » Recent market trends and its potential for future growth » Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-over-year growth, competitive benchmarking, vendor identification, CMI quadrant, and other significant analysis, as well as development status. » The report evaluates the current opportunity and future growth potential of the Controlled Release Drug Delivery market, providing estimates for its mid-to-long term evolution during the forecast period 2023-2029, aiming to identify potential trends and opportunities.
» Key companies manufacturing Controlled Release Drug Delivery worldwide are profiled, providing an overview of their financials, product portfolio, recent developments, and future outlook. » The research provides a comprehensive overview of the current state of the Controlled Release Drug Delivery market and its anticipated future evolution. **Note - Updated Version 2023 is available
#ORBIS CORPORATION ANNUAL REPORT FREE#
Request for a free sample copy of this report-> It is expected to reach above USD 78.41 billion by 2029 from USD 39.88 billion in 2020." "The global controlled release drug delivery market size is expected to grow at 7.8% CAGR from 2022 to 2029.
0 kommentar(er)
